The relationship of soluble urokinase plasminogen activator receptor levels with preterm premature rupture of membranes and predictive value in neonatal intensive care unit admission
Open Access
- 1 January 2026
- journal article
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (2) , e20251351
Abstract
SUMMARY OBJECTIVE: Preterm premature rupture of membranes is a pregnancy complication in which infection and inflammation play an important role. Soluble urokinase plasminogen activator receptor has been described as a biomarker of infectious and inflammatory diseases. The aim of this study was to evaluate maternal serum soluble urokinase plasminogen activator receptor levels in pregnant women with preterm premature rupture of membranes and to determine the predictive value in neonatal outcomes. METHODS: In this prospective case-control study, complete blood count parameters, serum C-reactive protein, and soluble urokinase plasminogen activator receptor levels of 40 pregnant women with preterm premature rupture of membranes and 40 randomly selected healthy pregnant women between 22 and 34 weeks’ gestation were recorded. Neutrophil-to-lymphocyte ratio, systemic inflammation response index, and systemic immune-inflammation index were calculated. Receiver operating characteristic analysis assessed the predictive value of maternal serum soluble urokinase plasminogen activator receptor levels for neonatal intensive care unit admission. RESULTS: Maternal serum soluble urokinase plasminogen activator receptor levels, neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, and systemic inflammation response index scores were significantly higher in the preterm premature rupture of membranes group than in controls (p<0.05). The soluble urokinase plasminogen activator receptor value in receiver operating characteristic analysis identified 4.33 ng/mL (62% sensitivity, 64% specificity) and 3.65 ng/mL (72% sensitivity, 73% specificity) for neonatal intensive care unit admission and adverse perinatal outcomes in the preterm premature rupture of membranes group (p<0.05). CONCLUSION: Soluble urokinase plasminogen activator receptor may be used as an ancillary marker in the prediction of neonatal intensive care unit admission and adverse perinatal outcome in preterm premature rupture of membranes cases, along with clinical findings.Keywords
This publication has 20 references indexed in Scilit:
- uPAR, IL-33, and ST2 Values as a Predictor of Subclinical Chorioamnionitis in Preterm Premature Rupture of MembranesJournal of Interferon & Cytokine Research, 2013
- Usefulness of Soluble Urokinase Plasminogen Activator Receptor to Predict Repeat Myocardial Infarction and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous InterventionThe American Journal of Cardiology, 2012
- Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic reviewIntensive Care Medicine, 2012
- Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patientsCritical Care, 2011
- Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsiaClinical Chemistry and Laboratory Medicine (CCLM), 2011
- A multicenter study on the clinical outcome of chorioamnionitis in preterm infantsAmerican Journal of Obstetrics and Gynecology, 2009
- Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective studyCritical Care, 2007
- Preterm Premature Rupture of the Membranes: Current Approaches to Evaluation and ManagementObstetrics and Gynecology Clinics of North America, 2005
- Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritisAnnals of the Rheumatic Diseases, 1999
- Risk factors for preterm premature rupture of fetal membranes: A multicenter case-control studyAmerican Journal of Obstetrics and Gynecology, 1990